The Quest for Optimal Therapy: Sofosbuvir and Ribavirin in Chronic Hepatitis C - A Systematic Review
DOI:
https://doi.org/10.56570/jimgs.v2i2.126Keywords:
Sofosbuvir, Ribavirin, Chronic Hepatitis-C, Cirrhosis, Safety, EfficacyAbstract
Chronic Hepatitis C (CHC) infection leads to liver
cirrhosis, liver failure and hepatocellular carcinoma. It
is mostly treated with Sofosbuvir and ribavirin or in
combination with other Direct-acting antivirals (DAAs)